These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37593577)

  • 1. Discovery of imeglimin-inspired novel 1,3,5-triazine derivatives as antidiabetic agents in streptozotocin-induced diabetes in Wistar rats
    Gupta A; Bhat HR; Singh UP
    RSC Med Chem; 2023 Aug; 14(8):1512-1536. PubMed ID: 37593577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel 1,3,5-triazine derivatives as an antidiabetic agent in Wistar rats via inhibition of DPP-4.
    Gupta A; Bhat HR; Singh UP
    Future Med Chem; 2023 May; 15(10):829-852. PubMed ID: 37307171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Discovery of Novel 1,3,5-Triazines as Dipeptidyl Peptidase-4 Inhibitor against Diabetes.
    Wang Y; Tang X; Yi L
    Pharmacology; 2019; 103(5-6):273-281. PubMed ID: 30799431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Patel BD; Bhadada SV; Ghate MD
    Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors.
    Sharma M; Gupta M; Singh D; Kumar M; Kaur P
    Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of triazole-based uracil derivatives bearing amide moieties as novel dipeptidyl peptidase-IV inhibitors.
    Deng X; Han L; Zhou J; Zhang H; Li Q
    Bioorg Chem; 2017 Dec; 75():357-367. PubMed ID: 29096096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors.
    Liu Y; Si M; Tang L; Shangguan S; Wu H; Li J; Wu P; Ma X; Liu T; Hu Y
    Bioorg Med Chem; 2013 Sep; 21(18):5679-87. PubMed ID: 23938053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic activity of
    Mohanty IR; Kumar CS; Borde M
    Indian J Pharmacol; 2021; 53(5):384-387. PubMed ID: 34854407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidyl peptidase IV Inhibitory activity of Terminalia arjuna attributes to its cardioprotective effects in experimental diabetes: In silico, in vitro and in vivo analyses.
    Mohanty IR; Borde M; Kumar C S; Maheshwari U
    Phytomedicine; 2019 Apr; 57():158-165. PubMed ID: 30668318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose regulation by newly synthesized boronic acid functionalized molecules as dipeptidyl peptidase IV inhibitor: a potential compound for therapeutic intervention in hyperglycaemia.
    Prajapati N; Sharma D; Ashok Bidve P; ; Chouhan D; Allani M; Kumar Patel S; Ghosh Chowdhury M; Shard A; Tiwari V
    J Biomol Struct Dyn; 2024 Apr; 42(6):2859-2871. PubMed ID: 37254302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of zonulin and GLP-1/DPP-IV in alleviation of diabetes mellitus by peptide/polypeptide fraction of Aloe vera in streptozotocin- induced diabetic wistar rats.
    Babu SN; Govindarajan S; Vijayalakshmi MA; Noor A
    J Ethnopharmacol; 2021 May; 272():113949. PubMed ID: 33610707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Amylase and dipeptidyl peptidase-4 (DPP-4) inhibitory effects of
    Quek A; Kassim NK; Lim PC; Tan DC; Mohammad Latif MA; Ismail A; Shaari K; Awang K
    Pharm Biol; 2021 Dec; 59(1):964-973. PubMed ID: 34347568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihyperglycemic effects of ASP8497 in streptozotocin-nicotinamide induced diabetic rats: comparison with other dipeptidyl peptidase-IV inhibitors.
    Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Hayakawa M; Shibasaki M
    Pharmacol Rep; 2009; 61(5):899-908. PubMed ID: 19904014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
    Musoev A; Numonov S; You Z; Gao H
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Glycation-Inflammation Modulation, DPP-IV and Pancraetic Lipase Inhibitory Potentials and Antiproliferative Activity of Novel Fluoroquinolones.
    Arabiyat S; Kasabri V; Al-Hiari Y; Al-Masri I; Alalawi S; Bustanji Y
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2503-2514. PubMed ID: 31450926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of anthraquinones as DPP-IV inhibitors: Structure-activity relationships and inhibitory mechanism.
    Ma HH; Zhang J; Li CQ; Zou LW
    Fitoterapia; 2023 Jul; 168():105549. PubMed ID: 37244503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity.
    Yeh KC; Yeh TK; Huang CY; Hu CB; Wang MH; Huang YW; Chou LH; Ho HH; Song JS; Hsu T; Jiaang WT; Chao YS; Chen CT
    Life Sci; 2021 Aug; 278():119574. PubMed ID: 33961850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local anaesthetic procaine derivatives protect rat against diabetic nephropathy via inhibition of DPP-4, inflammation and oxidative stress.
    Song M; Chen Y
    Chem Biol Drug Des; 2023 Jul; 102(1):26-37. PubMed ID: 37076428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo.
    Someya Y; Tahara A; Nakano R; Matsuyama-Yokono A; Nagase I; Fukunaga Y; Takasu T; Hayakawa M; Shibasaki M
    Naunyn Schmiedebergs Arch Pharmacol; 2008 May; 377(3):209-17. PubMed ID: 18398600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Galangin as a Potential DPP-4 Inhibitor That Improves Insulin-Stimulated Skeletal Muscle Glucose Uptake: A Combinational Therapy for Diabetes.
    Kalhotra P; Chittepu VCSR; Osorio-Revilla G; Gallardo-Velázquez T
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.